Blindness breakthrough as new jab could save sight of hundreds of thousands

Eye experts are leading a landmark trial in the UK of a new drug that could slow the progression of an untreatable form of blindness.

Patients who have suffered some visual loss due to geographic atrophy (GA) – an advanced form of dry age-related macular degeneration (AMD) – are receiving injections of lampalizumab.

It is believed the treatment, now in its final clinical trial phase, could reduce the area of damage in most sufferers by around 20%.

Some with a particular genetic feature could see the damage reduced by 44%, according to experts at Southampton General Hospital who are leading the UK trials.

The condition, which occurs when cells in the part of the eye responsible for vision become damaged by the build-up of waste deposits called drusen, causes progressive and permanent vision loss.

Despite accounting for 90% of all cases of AMD – the leading cause of blindness in the UK affecting around 500,000 people over the age of 50 – there are no approved treatments for either the early, intermediate or advanced forms of dry AMD.

Professor Andrew Lotery, a consultant ophthalmologist at Southampton General Hospital and the study’s chief investigator in the UK, said the study was a “major milestone” for patients and clinicians.

He said: “Lampalizumab has already been shown to reduce damage caused by GA by 20% in most cases and, for some patients with a specific genetic biomarker, by up to 44% in early-stage trials.

Read more: Blindness breakthrough as new jab could save sight of hundreds of thousands of Britons


See Also

The Latest on: Age-related macular degeneration

[google_news title=”” keyword=”Age-related macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News


The Latest on: Age-related macular degeneration
  • Cataract Surgery in Patients With Diabetes and Age-Related Macular Degeneration
    on May 23, 2024 at 5:01 pm

    The timing of surgery is critical as an unclear view of the retina may delay possible treatment for neovascular age-related macular degeneration (e.g., with photodynamic therapy). Patients should ...

  • Age related macular degeneration: What to ask your doctor
    on May 22, 2024 at 5:00 pm

    We've tried to contact you several times as we haven't been able to take payment. You must update your payment details via My Account or by clicking update payment details to keep your ...

  • New Treatment for Age-Related Macular Degeneration
    on May 22, 2024 at 5:00 pm

    Neovascularization is responsible for severe vision loss in patients with age-related macular degeneration (AMD). A promising approach to this problem is to inhibit vascular endothelial growth ...

  • FDA Approves Biosimilars for Macular Degeneration Treatment
    on May 22, 2024 at 7:56 am

    The FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work the same way as Eylea which prevents abnormal blood vessel growth in the eye and helps preserve ...

  • Age-Related Macular Degeneration: Putting a Hole in Our World
    on May 10, 2024 at 12:04 pm

    Estimates show that by 2040, age-related macular degeneration may affect nearly 300 million people worldwide. And we are very limited in our ability to treat or prevent it. Here's what to know.

  • Wet vs. Dry Age-Related Macular Degeneration (AMD)
    on May 9, 2024 at 8:29 pm

    Wet macular degeneration always begins with dry AMD, says Mayo Clinic. Both dry and wet age-related macular degeneration (AMD) involve changes to the macula, part of the retina in your eye.

  • Macular Degeneration
    on May 5, 2024 at 5:00 pm

    This is also called age-related macular degeneration (AMD), as the major risk factor for this is aging. It is an eye disorder characterized by a number of conditions negatively affecting the macula.

  • Age-Related Macular Degeneration
    on March 11, 2024 at 1:00 am

    For more information on Age-Related Macular Degeneration go to the NHS website. If you've had a diagnosis, in addition to support from your specialist, you may find it useful to use support groups ...

  • What Is Wet Age-Related Macular Degeneration?
    on February 25, 2024 at 12:34 pm

    To help detect or confirm a diagnosis of wet AMD, your doctor may perform other tests and procedures, including the following: Both dry and wet age-related macular degeneration (AMD) involve ...

via  Bing News


What's Your Reaction?
Don't Like it!
I Like it!
Scroll To Top